Veröffentlichungen

DatumTitelAutorMagazin
01/04/2012Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful   prognostic value in patients with multiple myeloma  Kassambara AHaematologica
31/07/2012Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor   Prognosis in Multiple Myeloma  Kassambara APLoS One
01/08/2012Antiangiogenic Therapeutic   Approaches in Multiple Myeloma Ribatti DCurrent Cancer Drug Targets
18/10/2012Development of gene expression   based score to predict sensitivity of multiple myeloma cells to DNA   methylation inhibitors Moreaux JMolecular Cancer Therapeutics
27/10/2012Dll1/Notch activation   contributes to bortezomib resistance  by upregulating CYP1A1 in multiple   myeloma. Xu DBiochemical and Biophysical   Research Communications
03/11/2012 Residual malignant and normal   plasma cells shortly after high dose melphalan and stem cell transplantation.   Highlight of a putative therapeutic window in Multiple Myeloma?  Caraux AOncotarget
01/12/2012STEAP1 is overexpressed in   cancers: A promising therapeutic target Moreaux JBiochemical and Biophysical   Research Communications
01/01/2013 Pentraxin 3 (PTX3) inhibits   plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma   patients.  Basile A.Journal of Pathology
30/01/2013 Multiple myeloma macrophages:   pivotal players in the tumor microenvironment  Berardi SJournal of Oncology
01/03/2013 The role of angiogenesis in   human non-Hodgkin lymphomas  Ribatti DNeoplasia
01/04/2013 Exome sequencing in tracking   clonal evolution in multiple myeloma following therapy.  Weston-Bell NLeukemia
12/04/2013 Kruppel-like factor 4 blocks   tumor cell proliferation and promotes drug resistance in multiple myeloma.  Schoenhals MHaematologica
19/04/2013 Tumor cells in multiple myeloma   patients inhibit myeloma-reactive T cells through carcinoembryonic   antigen-related cell adhesion molecule-6  Witzens-Harig   MNeben KBlood
30/04/2013 Inhibition of DEPDC1A, a bad   prognostic marker in multiple myeloma, delays growth and induces mature   plasma cell markers in malignant plasma cells  Kassambara APLoS One
01/05/2013 Heparan sulfate proteoglycans in   the control of B cell development and the pathogenesis of multiple myeloma  Reijmers, R MFEBS Journal
26/06/2013 Novel targeting of phospho-cMET   overcomes drug resistance and induces anti-tumor activity in multiple   myeloma  Moschetta MClinical Cancer Research
01/08/2013 The hypoxia target   adrenomedullin is aberrantly expressed in multiple myeloma and promotes   angiogenesis  Kocemba K ALeukemia
21/08/2013MHC Class I Antigen Processing   and Presenting Machinery: Organization, Function, and Defects in Tumor Cells Leone PJournal of the National Cancer   Institute
01/09/2013DNA repair pathways in human   multiple myeloma Gourzones-   Dmitriev CCell Cycle
01/10/2013 Erythropoietin is involved in   the angiogenic potential of bone marrow macrophages in multiple myeloma  De Luisi AAngiogenesis
01/12/2013 Progression in Smoldering   Myeloma Is Independently Determined by the Chromosomal Abnormalities   del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load  Neben KJournal of Clinical Oncology
26/12/2013The Glycome of Normal and   Malignant Plasma Cells Moehler T MPLoS One
01/01/2014 Bone marrow vascular niche and  the control of angiogenesis in multiple myeloma  Ribatti DFrontiers in Bioscience
01/02/2014 DNA methylation score is   predictive of myeloma cell sensitivity to 5-azacitidine  Moreaux JBritish Journal of Haematology
15/02/2014 HIF-1  of Bone Marrow   Endothelial Cells Implies Relapse and Drug Resistance in Patients with   Multiple Myeloma and May Act as a Therapeutic Target  Ria RClinical Cancer Research
01/04/2014 Bone marrow fibroblasts parallel   multiple myeloma progression in patients and mice: in vitro and in vivo   studies  Frassanito   Dammacco M ALeukemia
01/05/2014Microenvironment and multiple   myeloma spread Ribatti DThrombosis Research
15/05/2014 A DNA repair pathway score   predicts survival in human multiple myeloma: the potential for therapeutic  strategy  Kassambara AOncotarget
01/08/2014 IL-6 supports the generation of   human long-lived plasma cells in combination with either APRIL or stromal   cell-soluble factors  Jourdan MLeukemia
01/08/2014Role of endothelial progenitor   cells in cancer progression Moschetta MBiochimica et Biophysica Acta –   Reviews on Cancer
01/08/2014 Therapeutic targeting of the  mTOR-signalling pathway in cancer: benefits and limitations  Moschetta MBritish Journal of Pharmacology
01/09/2014 Cancer Associated Fibroblasts   and Tumor Growth: Focus on Multiple Myeloma  Veirman KCancers
26/09/2014 Preclinical efficacy of   sepantronium bromide (YM155) in multiple myeloma is conferred by down   regulation of Mcl-1  Wagner VOncotarget
01/10/2014Macrophages in multiple myeloma Ribatti DImmunology Letters
15/11/2014 A HGF/cMET Autocrine Loop Is   Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent  a Novel Therapeutic Target  Ferrucci AClinical Cancer Research
01/12/2014 Stimulation of invariant natural   killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in   endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model  Haneen NBritish Journal of Haematology
08/12/2014Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies Veirman KFrontiers in Oncology
01/01/2015Identify multiple myeloma stem   cells: Utopia? Saltarella, IWorld Journal of Stem Cells
29/01/2015 GenomicScape: An Easy-to-Use Web   Tool for Gene Expression Data Analysis. Application to Investigate the   Molecular Events in the Differentiation of B Cells into Plasma Cells  Kassambara, APLoS Computational Biology
01/02/2015 Cellular uptake kinetics of   bortezomib in relation to efficacy in myeloma cells and the influence of drug   transporters  Clemens, CCancer Chemotherapy &   Pharmacology
20/02/2015 In vivo treatment with   epigenetic modulating agents induces transcriptional alterations associated   with prognosis and immunomodulation in multiple myeloma  Maes KOncotarget
20/02/2015Cancer associated fibroblasts in   hematological malignancies Raffaghello LOncotarget
01/03/2015 The 7p15.3 (rs4487645)   association for multiple myeloma shows strong allele-specific regulation of   the MYC-interacting gene CDCA7L in malignant plasma cells  Weinhold NHaematologica
20/03/2015 Drug metabolism and clearance   system in tumor cells of patients with multiple myeloma  Hassen WOncotarget
01/04/2015 Association of Antigen-Specific   T-cell Responses with Antigen Expression and Immunoparalysis in Multiple   Myeloma  Fichtner SClinical Cancer Research
30/04/2015 Multiple myeloma induces Mcl-1   expression and survival of myeloid-derived suppressor cells  De Veirman KOncotarget
30/05/2015 Massive parallel IGHV gene   sequencing reveals a germinal center pathway in origins of human multiple   myeloma.  Cowan GOncotarget
01/07/2015 Myeloma cells act as tolerogenic   antigen-presenting cells and induce regulatory T cells in vitro   Frassanito MAEuropean Journal of Haematology